(19)
(11) EP 2 925 312 A1

(12)

(43) Date of publication:
07.10.2015 Bulletin 2015/41

(21) Application number: 13858101.2

(22) Date of filing: 21.11.2013
(51) International Patent Classification (IPC): 
A61K 31/277(2006.01)
A61P 3/04(2006.01)
A61P 3/06(2006.01)
A61P 9/12(2006.01)
A61P 13/12(2006.01)
A61P 3/00(2006.01)
A61P 3/10(2006.01)
A61P 9/00(2006.01)
A61P 9/10(2006.01)
A61P 1/16(2006.01)
(86) International application number:
PCT/CN2013/087581
(87) International publication number:
WO 2014/082544 (05.06.2014 Gazette 2014/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 28.11.2012 CN 201210497436

(71) Applicant: National Institute Of Biological Sciences, Beijing
Beijing 102206 (CN)

(72) Inventors:
  • HUANG, Niu
    Beijing 102206 (CN)
  • ZHI, Gang
    Beijing 102206 (CN)
  • CHAI, Jijie
    Beijing 102206 (CN)
  • PENG, Shiming
    Beijing 102206 (CN)
  • HOU, Nannan
    Beijing 102206 (CN)

(74) Representative: Viering, Jentschura & Partner Patent- und Rechtsanwälte 
Kennedydamm 55 / Roßstrasse
40476 Düsseldorf
40476 Düsseldorf (DE)

   


(54) ENTACAPONE FOR PREVENTION AND TREATMENT OF OBESITY AND RELATED METABOLIC DISEASES